Mohamed Hebbar

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +14

Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

Dorothée Duluc, Yves Delneste, Fang Tan et al. · Blood · 2007 · 474 citations · Full text

Life Sciences, Immunology, Oncology +16

Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis

Yasmine Touil, Wassila Igoudjil, Matthieu Corvaisier et al. · Clinical Cancer Research · 2013 · 341 citations

Medicine, Cell Biology, Oncology +17

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 324 citations · Full text

Medicine, Oncology, Surgery +14

Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages

Dorothée Duluc, Murielle Corvaisier, Simon Blanchard et al. · International Journal of Cancer · 2009 · 317 citations

Medicine, Immunology, Oncology +17